메뉴 건너뛰기




Volumn 3, Issue 6, 1996, Pages 588-589

Multi-institutional melanoma vaccine trial

Author keywords

Melanoma; Melanoma Vaccine; Public Health; Vaccine Trial

Indexed keywords

ACTIVE IMMUNIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LETTER; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030278822     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1007/BF02306095     Document Type: Letter
Times cited : (2)

References (2)
  • 1
    • 0030097414 scopus 로고    scopus 로고
    • Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma, vaccine trial
    • COI: 1:STN:280:BymB3snltlw%3D, PID: 8646509
    • Wallack MK, Sivanandham M, Whooley B, Ditaranto K, Bartolucci AA. Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma, vaccine trial.Ann Surg Oncol 1996;3:110–7.
    • (1996) Ann Surg Oncol , vol.3 , pp. 110-117
    • Wallack, M.K.1    Sivanandham, M.2    Whooley, B.3    Ditaranto, K.4    Bartolucci, A.A.5
  • 2
    • 0025737883 scopus 로고
    • Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials
    • COI: 1:STN:280:By6B2MbmslA%3D
    • Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.J Am Med Assoc 1991;266:93–8. DOI: 10.1001/jama.266.1.93
    • (1991) J Am Med Assoc , vol.266 , pp. 93-98
    • Yusuf, S.1    Wittes, J.2    Probstfield, J.3    Tyroler, H.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.